Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/2003
02/25/2003US6525085 Diaryl-enynes
02/25/2003US6525083 Antidiabetic agents, antilipemic agents, anticholesterol agents
02/25/2003US6525075 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
02/25/2003US6525073 Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
02/25/2003US6525067 Substituted heterocyclic derivatives
02/25/2003US6525062 Method of treating pain using nalbuphine and opioid antagonists
02/25/2003US6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/25/2003US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
02/25/2003US6525045 Positive allosteric AMPA receptor modulators
02/25/2003US6525044 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
02/25/2003US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders
02/25/2003US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia
02/25/2003US6524629 20-30% of flavoneglycosides, 2.5-4.5% of ginkgolides A, B, C, and J, 2-4% of biloblaide, < 10% proanthocyanidines, < 10 ppm of an alkylphenol and ginkobiloba extract
02/25/2003US6524623 Therapeutic compositions and methods of use thereof
02/25/2003US6524607 Nontoxic, nonglucocorticoid, biocompatible, biodegradable, controlled release material
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003WO2002016354A1 Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors
02/21/2003CA2420206A1 Chromenone derivatives and the use thereof for the treatment of diseases in connection with 5-hta1 receptors and/or dopamine d2 receptors
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
02/20/2003WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/20/2003WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1
02/20/2003WO2003014322A2 Proteins associated with cell growth, differentiation, and death
02/20/2003WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation
02/20/2003WO2003014309A2 Interleukin-1 receptors in the treatment of diseases
02/20/2003WO2003014287A1 Hops extracts, method for the production and use
02/20/2003WO2003014145A2 Peptides that bind to atherosclerotic lesions
02/20/2003WO2003014137A1 Adenosine a3 receptor agonists
02/20/2003WO2003014125A1 Therapeutically useful tetracyclic ligands
02/20/2003WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
02/20/2003WO2003014122A1 Derivatives of morphine-like opioid compounds
02/20/2003WO2003014121A1 Compounds, derivatives, compositions, preparation and uses
02/20/2003WO2003014118A1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
02/20/2003WO2003014114A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/20/2003WO2003014112A1 Crystal and process for producing the same
02/20/2003WO2003014101A1 Hydroxamic acid derivatives
02/20/2003WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014097A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity
02/20/2003WO2003014095A1 Acylaminothiazole derivatives, their preparation and therapeutic use
02/20/2003WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003014080A2 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
02/20/2003WO2003014079A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
02/20/2003WO2003014075A2 Novel gamma secretase inhibitors
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2003013655A2 Carbonic anhydrase inhibitors
02/20/2003WO2003013611A1 Percutaneous absorption preparations
02/20/2003WO2003013574A1 Melanin-concentrating hormone antagonists
02/20/2003WO2003013563A2 Mineral-protein preparations (mpp) and neuropathies in diabetes
02/20/2003WO2003013562A1 Artichoke leaf extracts
02/20/2003WO2003013549A2 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013539A1 Neuroprotective drug
02/20/2003WO2003013538A1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent
02/20/2003WO2003013537A2 Irinotecan for treatment of cancer
02/20/2003WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003WO2003013532A1 Chiral dinapsoline
02/20/2003WO2003013531A1 Phenyl derivatives as factor xa inhibitors
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2003013529A1 Paroxetine glycyrrhizinate
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003WO2003013525A1 Opioid agonist formulations with releasable and sequestered antagonist
02/20/2003WO2003013522A1 Preventives/remedies for cholinergic neuropathy
02/20/2003WO2003013521A1 Compounds for eliminating and/or relieving anhedonia
02/20/2003WO2003013520A1 Pramipexole for the treatment of adhd
02/20/2003WO2003013519A1 Pramipexol as an anticonvulsive agent
02/20/2003WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors
02/20/2003WO2003013514A1 Improving neurological functions
02/20/2003WO2003013513A1 Stable emulsion composition
02/20/2003WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
02/20/2003WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands
02/20/2003WO2003013508A1 Therapeutic agent for depletion of an unwanted protein population from plasma
02/20/2003WO2003013506A1 Sulphonamides for control of beta-amyloid production
02/20/2003WO2003013497A1 Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
02/20/2003WO2003013495A1 Formulation and method for reduction of stress in meat-producing animals
02/20/2003WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
02/20/2003WO2003013492A1 Combination therapy for the treatment of neurological disorders
02/20/2003WO2003013479A1 Compositions and methods to prevent abuse of opioids
02/20/2003WO2003013476A1 Compositions and methods to prevent abuse of opioids
02/20/2003WO2003013470A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
02/20/2003WO2003013442A2 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
02/20/2003WO2003013437A2 Compositions and methods for the prevention and treatment of huntington's disease
02/20/2003WO2003013436A2 Kavalactone compositions and methods of use
02/20/2003WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace
02/20/2003WO2003013433A2 Sequestered antagonist formulations
02/20/2003WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment
02/20/2003WO2002102794A3 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
02/20/2003WO2002100858A3 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
02/20/2003WO2002098427A3 Sustained-release analgesic compounds
1 ... 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 ... 1833